全文获取类型
收费全文 | 1291篇 |
免费 | 94篇 |
国内免费 | 32篇 |
专业分类
耳鼻咽喉 | 8篇 |
儿科学 | 70篇 |
妇产科学 | 21篇 |
基础医学 | 163篇 |
口腔科学 | 79篇 |
临床医学 | 183篇 |
内科学 | 205篇 |
皮肤病学 | 14篇 |
神经病学 | 64篇 |
特种医学 | 261篇 |
外科学 | 104篇 |
综合类 | 25篇 |
预防医学 | 90篇 |
眼科学 | 5篇 |
药学 | 75篇 |
肿瘤学 | 50篇 |
出版年
2022年 | 7篇 |
2021年 | 11篇 |
2020年 | 5篇 |
2019年 | 8篇 |
2018年 | 19篇 |
2017年 | 9篇 |
2016年 | 10篇 |
2015年 | 17篇 |
2014年 | 22篇 |
2013年 | 17篇 |
2012年 | 24篇 |
2011年 | 31篇 |
2010年 | 49篇 |
2009年 | 30篇 |
2008年 | 30篇 |
2007年 | 55篇 |
2006年 | 39篇 |
2005年 | 29篇 |
2004年 | 27篇 |
2003年 | 40篇 |
2002年 | 36篇 |
2001年 | 42篇 |
2000年 | 39篇 |
1999年 | 35篇 |
1998年 | 73篇 |
1997年 | 77篇 |
1996年 | 82篇 |
1995年 | 55篇 |
1994年 | 42篇 |
1993年 | 47篇 |
1992年 | 27篇 |
1991年 | 21篇 |
1990年 | 29篇 |
1989年 | 47篇 |
1988年 | 46篇 |
1987年 | 38篇 |
1986年 | 31篇 |
1985年 | 40篇 |
1984年 | 12篇 |
1983年 | 11篇 |
1982年 | 15篇 |
1981年 | 10篇 |
1980年 | 16篇 |
1979年 | 5篇 |
1978年 | 6篇 |
1977年 | 16篇 |
1976年 | 11篇 |
1975年 | 10篇 |
1972年 | 3篇 |
1966年 | 3篇 |
排序方式: 共有1417条查询结果,搜索用时 15 毫秒
1.
Isolated patellofemoral arthritis is an increasingly recognized entity, and is usually associated with previous patellofemoral dysplasia or instability. Patellofemoral arthroplasty (PFA) has evolved significantly in recent years, both in terms of implant design and importantly in the understanding of appropriate patient selection. This review outlines the indications and investigations for PFA, provides a brief history of the development of contemporary implants, and presents the clinical outcomes for the prostheses most commonly used in the UK. In addition, it provides a detailed surgical technique for implantation of an onlay implant, with tips on how to optimize patellofemoral biomechanics and thus achieve a consistently good outcome. 相似文献
2.
3.
Sonoelasticity imaging of prostate cancer: in vitro results 总被引:2,自引:0,他引:2
4.
5.
6.
R. J. Rona A. V. Swan R. Beech D. M. Wilson F. B. Kavanagh C. Brown C. Axtell S. Mandalia 《Clinical genetics》1992,42(4):186-195
For certain genetic conditions DNA testing identifies carriers and determines the risk status of foetuses, thus helping parents to make more informed prenatal decisions. Data, collected from three genetic centres in England and Wales from August 1986 to July 1990, are used to describe trends in demand for DNA testing, the impact of DNA tests on carrier risk assessment, and the use of DNA tests in relation to pregnancy outcome. Altogether the data include 23,388 subjects and 681 pregnancies in 8738 families divided into five cohorts by year of entry and referral. The most frequent gene disorders referred to the genetic centres are currently being tested or will soon be tested. For these disorders the initial high level of activity has declined and may have reached steady state. Demand for DNA services is high for cystic fibrosis and Duchenne muscular dystrophy, intermediate for Huntington's disease, and low for adult polycystic kidney disease, phenylketonuria and tuberous sclerosis. Based on these findings we suggest that demand for DNA tests will be high in serious, untreatable and slow progressing conditions with early onset; intermediate for conditions affecting intellect and neurological integrity with later onset; and low for treatable, late-onset conditions, or those for which there is evidence of heterogeneity, and variable penetrance. It would be helpful to assess the extent to which this view of demand is confirmed when the new disorders being DNA tested are considered and for the pattern of activity of DNA testing for some types of cancer. Since no DNA centre could offer a fully comprehensive testing service, it is recommended that a structure is created to audit overall activity, assist in policy formulation, and influence supraregional service organisation, in order that the spread of DNA services be planned as effectively as possible. This structure would facilitate monitoring of the evolution of contract specifications agreed by commissioners and providers on a regional basis. 相似文献
7.
D Anderson S Goyle B J Phillips A Tee L Beech W H Butler 《Occupational and environmental medicine》1988,45(4):269-274
Since the Bhopal disaster, in which the causal agent was methyl isocyanate (MIC), exposed people have complained of various disorders including neuromuscular dysfunction. In an attempt to gain some information about the response of muscle tissue to MIC its effects were investigated in cells in culture isolated from muscle of 2 day old rats. After treatment with a range of MIC concentrations (0.025-0.5 microliter/5 ml culture) the total number of nuclei of the two main cell types (fibroblasts and myoblasts) and the number of nuclei in muscle fibres (myotubes) were recorded. At lower doses which had little effect on the total number of nuclei, the formation of muscle fibres--that is, fusion of muscle cells--was prevented as the proportion of nuclei in myotubes was decreased. At higher doses both cell types were killed. This would suggest either an effect on muscle differentiation or a selective toxicity towards myoblasts. The observations were supported by light and electron microscopy. 相似文献
8.
9.
10.
Ten thrombocytopenic patients (platelets < 10–24 × 10(9)/L) who were refractory to platelet transfusion were investigated for their responsiveness to staphylococcal protein A column therapy. Nine patients had previously been treated with steroids, intravenous immune globulin, and/or other forms of immunosuppressive therapy without improvement in their transfusion response. All patients were receiving multiple platelet transfusions without achieving 1-hour corrected count increments (CCIs) > or = 7500. Eight patients had antibodies that reacted with platelets and were directed against HLA class I antigens, ABO antigens, and/or platelet-specific alloantigens. Plasma (500-2000 mL) from each patient was passed over a protein A silica gel column and then returned to the patient. Patients received from 1 to 14 treatments. A positive response to protein A therapy was defined as at least a doubling of the pretreatment platelet count and/or two successive 10- to 120-minute posttransfusion CCIs > or = 7500. Following plasma treatments, 6 of 10 patients responded with daily platelet counts that averaged 48 +/− 11 × 10(9) per L as compared with counts of 16 +/− 7 × 10(9) per L (p < 0.0005) before treatment. Posttransfusion CCI values determined in four of these patients averaged 2480 +/− 810 and 10,010 +/− 3540 (p < 0.005) before and after treatment, respectively. In contrast, among the four unresponsive patients, platelet counts averaged 10 +/− 9 and 13 +/− 10 × 10(9) per L (p = NS), respectively, while posttransfusion CCIs were 700 +/− 1410 and 1520 +/− 2460 (p = NS), respectively.(ABSTRACT TRUNCATED AT 250 WORDS) 相似文献